ENTOD PHARMACEUTICALS LTD incorporated as a company and started MARKETING exclusive OPHTHALMIC and ENT ranges by getting it manufactured from reputed companies. Set up its first manufacturing plant at MIDC, Rabale (Maharashtra, India) for manufacturing Sterile Dosage Forms. The first company to launch Hypromellose Eye Drops in India as inchLACRYL EYE DROPSinch. Set up its second manufacturing plant at MIDC, Ambernath (Maharashtra, India) for manufacturing Tablets, Liquids and Capsules dosage forms. Expansion of Rabale manufacturing plant and manufactured for various reputed companies such as M/s. Crossland, M/s. Indo Pharma. Started it's own marketing of Ophthalmic and ENT brands with 50 Medical representatives in different parts of India. Set up a separate formulation R and D at Rabale. Contract manufacturing for various Pharma Companies specialized in OPHTHALMIC and ENT Medicines. Established full fledged marketing department and expanded its Field Force to 100 Medical Representatives. The first company to launch Erythromycin Eye Ointment USP as inchOPTITHROCINinch. The first Indian company to launch a unique combination of Flurbiprofen and Chloramphenicol as inchFLUBICHLORinch. The first company to manufacture IN HOUSE OXYCHLORO COMPLEX as PRESERVATIVE for Opthalmic drops in India The first India company to launch Timolol Maleate with Oxychloro Complex as inchTIMOLPinch The first India company to launch a unique combination of Gatifloxacin with Flurbiprofen with Neutral pH as inchFLUBIGATinch a great success for its formulation R and D. Launch of inchLOC Tearsinch containing CMC, Glycerin with Compatible Solutes. Entod is continually expanding its innovative product range, rapidly developing its RandD facilities and growing its marketing field force to cover almost all parts of India.
Aim / Vision / Mission
ENTOD is a people oriented organisation. We are dedicated to the Innovation, Manufacturing and Marketing of the highest quality Pharmaceutical products that enhance the quality of life worldwide.
To bring to the market innovative, high quality health care products, offering real economic value.To pursue growth in new and emerging markets. To strive for effective cost management and efficiency so as to remain globally competitive.